Although FASL-mediated killing is often indiscriminate due to rather ubiquitous expression of FAS on mammalian tissues, TRAIL-mediated cytotoxicity is more selective toward virally infected cells and tumor cells, making it a potential target in immunotherapy (104). This evidence concerns the gene FASLG and neoplasm.